These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 27721418)

  • 1. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes.
    Nagaishi K; Mizue Y; Chikenji T; Otani M; Nakano M; Konari N; Fujimiya M
    Sci Rep; 2016 Oct; 6():34842. PubMed ID: 27721418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells.
    Nagaishi K; Ataka K; Echizen E; Arimura Y; Fujimiya M
    Hepatology; 2014 May; 59(5):1816-29. PubMed ID: 24375439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
    Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress.
    Lv S; Cheng J; Sun A; Li J; Wang W; Guan G; Liu G; Su M
    Diabetes Res Clin Pract; 2014 Apr; 104(1):143-54. PubMed ID: 24513119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
    Park JH; Hwang I; Hwang SH; Han H; Ha H
    Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
    Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y
    Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of bone marrow-derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy.
    Yamashita T; Fujimiya M; Nagaishi K; Ataka K; Tanaka M; Yoshida H; Tsuchihashi K; Shimamoto K; Miura T
    FASEB J; 2012 Apr; 26(4):1559-68. PubMed ID: 22198389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reducing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells.
    Li H; Rong P; Ma X; Nie W; Chen Y; Zhang J; Dong Q; Yang M; Wang W
    J Diabetes Res; 2020; 2020():3847171. PubMed ID: 32455132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
    Bai Y; Wang J; He Z; Yang M; Li L; Jiang H
    Med Sci Monit; 2019 Apr; 25():3069-3076. PubMed ID: 31023998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction.
    da Silva AF; Silva K; Reis LA; Teixeira VP; Schor N
    Cell Transplant; 2015; 24(12):2657-66. PubMed ID: 25695732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy.
    Nagaishi K; Mizue Y; Chikenji T; Otani M; Nakano M; Saijo Y; Tsuchida H; Ishioka S; Nishikawa A; Saito T; Fujimiya M
    Sci Rep; 2017 Aug; 7(1):8484. PubMed ID: 28814814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
    Kang MK; Park SH; Choi YJ; Shin D; Kang YH
    J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.
    Lv SS; Liu G; Wang JP; Wang WW; Cheng J; Sun AL; Liu HY; Nie HB; Su MR; Guan GJ
    Int Immunopharmacol; 2013 Oct; 17(2):275-82. PubMed ID: 23791972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis.
    Liu D; Liu F; Li Z; Pan S; Xie J; Zhao Z; Liu Z; Zhang J; Liu Z
    Cell Death Dis; 2021 Mar; 12(3):255. PubMed ID: 33692334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model.
    Chen L; Xiang E; Li C; Han B; Zhang Q; Rao W; Xiao C; Wu D
    J Diabetes Res; 2020; 2020():8035853. PubMed ID: 32405507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marrow mesenchymal stem cell mediates diabetic nephropathy progression via modulation of Smad2/3/WTAP/m6A/ENO1 axis.
    Bai Y; Huang L; Fan Y; Li Y
    FASEB J; 2024 Jun; 38(11):e23729. PubMed ID: 38847786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urotensin II Induces ER Stress and EMT and Increase Extracellular Matrix Production in Renal Tubular Epithelial Cell in Early Diabetic Mice.
    Pang XX; Bai Q; Wu F; Chen GJ; Zhang AH; Tang CS
    Kidney Blood Press Res; 2016; 41(4):434-49. PubMed ID: 27467277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model.
    An X; Liao G; Chen Y; Luo A; Liu J; Yuan Y; Li L; Yang L; Wang H; Liu F; Yang G; Yi S; Li Y; Cheng J; Lu Y
    Stem Cell Res Ther; 2019 Dec; 10(1):363. PubMed ID: 31791397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.